| #64 |
Daniel Goldstein |
Harvard University |
1 |
| #64 |
Gordon J. Freeman |
Dana-Farber Cancer Institute |
1 |
| #64 |
Debra Thompson |
— |
1 |
| #64 |
Howard A. Shuman |
Columbia University |
1 |
| #64 |
Joseph D. Gresser |
Cambridge Scientific |
1 |
| #64 |
Jeffrey C. Grossman |
MIT |
1 |
| #64 |
Marc Joshua Tolkoff |
Boston Scientific Limited |
1 |
| #64 |
Jonathan Reis |
Ptc Therapeutics Mp |
1 |
| #64 |
Vassiliki Boussiotis |
Dana-Farber Cancer Institute |
1 |
| #64 |
Nolan T. Flynn |
MIT |
1 |
| #64 |
Natan Parsons |
Arichell Technologies |
1 |
| #64 |
N. F. Yudanov |
AMD |
1 |
| #64 |
Magued Boshra NASR |
— |
1 |
| #64 |
Molly Kate Boie |
Geltex Pharmaceuticals |
1 |
| #64 |
Roger Sherman |
Tensor Consulting Co. |
1 |
| #64 |
Nikolai Yudanoy |
AMD |
1 |
| #64 |
Sabina Signorretti |
Dana-Farber Cancer Institute |
1 |
| #64 |
Michael F. Wilkemeyer |
Department Of Veterans Affairs |
1 |
| #64 |
Pamela Sklar |
Whitehead Institute For Biomedical Research |
1 |
| #64 |
Joseph Volpe |
Children'S Medical Center |
1 |
| #64 |
Ralph F. Cohn |
Boston Advanced Technologies |
1 |
| #64 |
James P. Koch |
Western Atlas |
1 |
| #64 |
Edna E. Sun |
Harvard University |
1 |
| #64 |
Caroline Shi |
— |
1 |
| #64 |
Yola Kateline Jean-George |
— |
1 |
| #64 |
Daniel J. Reilly |
Sensable Technologies |
1 |
| #64 |
Timothy J. Hawkey |
Diversified Technologies |
1 |
| #64 |
Massimo Pietropaolo |
Joslin Diabetes Center |
1 |
| #64 |
Yevgeniy Yakovlevich Dorfman |
Bbnt Solutions Llc. |
1 |
| #64 |
Vladimir Volloch |
— |
1 |
| #64 |
Marie-Laure Limousin |
GE |
1 |
| #64 |
Kyl V. Myrick |
Harvard University |
1 |